image
Phio Pharmaceuticals Corp. PHIO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.21
-0.897 %
$ 1.9 M
Market Cap
-0.14
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-10.8 M OPERATING INCOME
5.57%
Growth Rates
1Year 5.57%
3Years -7.17%
5Years -8.01%
7Years -2.65%
10Years 6.39%
-10.8 M NET INCOME
5.70%
Growth Rates
1Year 5.70%
3Years -7.18%
5Years -8.02%
7Years -2.68%
10Years 6.38%
EFFICIENCY
Earnings Waterfall Phio Pharmaceuticals Corp.
image
Revenue 0
Cost Of Revenue 6.33 M
Gross Profit -6.33 M
Operating Expenses 4.49 M
Operating Income -10.8 M
Other Expenses 2 K
Net Income -10.8 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
REVENUE
Revenue 0 0 0 0 21 K 0.1 15 K 19 K 34 K 71 K 0.4 97 K 0
GROSS PROFIT
Cost Of Revenue 6.3 0.2 0.2 0.2 4.3 K 4.3 5.4 5.4 6.9 5.7 17.7 13.0 0
Gross Profit (6.3) (0.2) (0.2) (0.2) 16.7 K (4.2) (5.4) (5.4) (6.9) (5.6) (17.3) (12.9) 0
OPERATING INCOME
Operating Expenses 4.5 11.5 13.5 8.8 9.0 7.5 9.4 9.0 10.3 8.9 21.3 13.1 12.8
Selling, General and Administrative Expenses 4.3 4.5 4.6 4.4 4.7 3.2 4.0 3.6 3.3 3.2 3.7 2.6 6.1
Research and Development Expenses 6.3 7.0 8.9 4.4 4.3 4.3 5.4 5.4 6.9 5.7 17.7 10.5 6.6
Operating Income (10.8) (11.5) (13.5) (8.8) (9.0) (7.4) (14.1) (9.0) (10.2) (8.8) (20.9) (13.0) (12.8)
PRE-TAX INCOME
Interest Income Expense 0 (0.2) 9 K 0 0 0 0 0 0 0 24 K 30 K 0
Total Other Income 2 K 18 K 0.2 1 K 79 K 4 K 11 K 21 K 14 K 26 K 24 K 0.1 2.6
Pre-Tax Income (10.8) (11.5) (13.3) (8.8) (8.9) (7.4) (14.1) (9.0) (10.2) (8.8) (20.9) (12.9) (10.2)
NET INCOME
Tax Provision 0 (0.2) 75 K (0.1) 67 K 4 K (1.6) 74 K 91 K (0.1) 0 95 K (2.6)
Net Income (10.8) (11.3) (13.2) (8.8) (8.8) (7.4) (12.5) (9.0) (10.2) (8.8) (20.9) (12.9) (10.2)
EPS 46.9 9.95 12.4 23 230 690 3.64 K 8.8 K 10.3 K 26.4 K (0.1) (0.2) (0.1)